Stimulating Adverse Drug Reaction Reporting.
- Published in:
- Drug Safety, 2003, v. 26, n. 14, p. 1049, doi. 10.2165/00002018-200326140-00005
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2003 AND VI 26 AND IP 14
Results: 8
1
2
A Benefit-Risk Assessment of Sibutramine in the Management of Obesity.
- Published in:
- Drug Safety, 2003, v. 26, n. 14, p. 1027, doi. 10.2165/00002018-200326140-00004
- By:
- Publication type:
- Article
3
Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads.
- Published in:
- 2003
- By:
- Publication type:
- journal article
4
Aluminium in over-the-counter drugs: risks outweigh benefits?
- Published in:
- 2003
- By:
- Publication type:
- journal article
5
Declaration of Fructose and Fructose-Related Adverse Effects in Commercial Drug Preparations in European Countries.
- Published in:
- Drug Safety, 2003, v. 26, n. 14, p. 1057, doi. 10.2165/00002018-200326140-00006
- By:
- Publication type:
- Article
6
Aluminium in Over-the-Counter Drugs.
- Published in:
- Drug Safety, 2003, v. 26, n. 14, p. 1011, doi. 10.2165/00002018-200326140-00003
- By:
- Publication type:
- Article
7
Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety.
- Published in:
- 2003
- By:
- Publication type:
- journal article
8
Health risks of counterfeit pharmaceuticals.
- Published in:
- 2003
- By:
- Publication type:
- journal article